Stocks · News reference

HLS Therapeutics Sees FY2026 Sales $56.000M-$60.000M vs $57.730M Est

Aug 12, 2026, 10:51 AMBenzinga Newsdesk

HLS Therapeutics (TSX:HLS) sees FY2026 sales of $56.000 million-$60.000 million vs $57.730 million analyst estimate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 12, 2026, 10:34 AMBenzinga Newsdesk
HLS Therapeutics Q2 EPS $(0.03) Beats $(0.10) Estimate, Sales $14.673M Beat $14.467M Estimate
HLS Therapeutics (TSX:HLS) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.10) by 70 percent. This is a 66.67 percent increase over losses of $(0.09) per share from the
Read original at benzinga
TSX:HLS